Acute respiratory failure due to COVID-19 pneumonia often requires a comprehensive
approach that includes non-pharmacological strategies such as non-invasive support …

Acute respiratory failure secondary to COVID-19 pneumonia may require a variety of non-
pharmacological strategies in addition to oxygen therapy to avoid endotracheal intubation …

Abstract Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a
newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019 …

Conclusion In conclusion, even if NIRT have been shown to be effective tools in preventing
ETI in COVID-19 acute respiratory failure, further studies designed to address important …

In the last 11 months, the SARS-CoV-2 pandemic has overwhelmed and disrupted the
whole world in health, social and economic terms. We are progressively learning more and …

Abstract COVID-19 related Acute Respiratory Failure, may be successfully treated with
Conventional Oxygen therapy, High Flow Nasal Cannula, Continuous Positive Airway …

Non-invasive ventilatory support (non-invasive ventilation, high-flow oxygen therapy, and
CPAP) is useful in patients with heart failure and decompensated chronic obstructive …

BACKGROUND: The roles of high-flow nasal cannula (HFNC) and CPAP in coronavirus
disease 2019 (COVID-19) are controversial. The objective of the study was to evaluate the …

INTRODUCTION: To date, a shared international consensus on treatment of Coronavirus
disease 2019 (COVID-19) with invasive or non-invasive respiratory support is lacking …

Dr. Gorman is an investigator on the Randomized Evaluation of COVID-19 Therapy–
Respiratory Support (RECOVERY-RS) trial investigating noninvasive respiratory support in …